--- title: "Tianda Pharmaceuticals (455) stock and investor profile" url: "https://aibio.space/companies/tianda-pharmaceuticals/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Tianda Pharmaceuticals Ltd. (HKEX: 455), Hong Kong. The directory classifies it as Pharmaceuticals: Major." --- 455 Tianda Pharmaceuticals Ltd. HKEX · Hong Kong # Tianda Pharmaceuticals (455) news Tianda Pharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 455, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Tianda Pharmaceuticals news We have not published a story on Tianda Pharmaceuticals yet. When there is news, it will appear here. ## Tianda Pharmaceuticals at a glance - **Ticker**: 455 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) HKEX: 8037 - [SSY Group](https://aibio.space/companies/ssy/) HKEX: 2005 - [Extrawell Pharmaceutical Holdings](https://aibio.space/companies/extrawell-pharmaceutical/) HKEX: 858 - [China Resources Pharmaceutical Group](https://aibio.space/companies/china-resources-pharmaceutical/) HKEX: 3320 - [HUTCHMED (China)](https://aibio.space/companies/hutchmed-china/) HKEX: 13 - [Pak Fah Yeow International](https://aibio.space/companies/pak-fah-yeow-international/) HKEX: 239 - [InSilico Medicine Cayman TopCo](https://aibio.space/companies/insilico-medicine-cayman-topco/) HKEX: 3696 - [Lee's Pharmaceutical Holdings](https://aibio.space/companies/lee-s-pharmaceutical/) HKEX: 950 ### Also on HKEX - [Medtide](https://aibio.space/companies/medtide/) 3880 - [Antengene Corporation](https://aibio.space/companies/antengene/) 6996 - [Edding Genor Group Holdings](https://aibio.space/companies/edding-genor/) 6998 - [Zai Lab](https://aibio.space/companies/zai-lab/) 9688 - [B&K Corporation](https://aibio.space/companies/b-k/) 2396 - [Pak Fah Yeow International](https://aibio.space/companies/pak-fah-yeow-international/) 239 ## Questions about Tianda Pharmaceuticals What is the ticker symbol of Tianda Pharmaceuticals? Tianda Pharmaceuticals Ltd. trades under the ticker 455 on HKEX. Where is Tianda Pharmaceuticals listed? Tianda Pharmaceuticals Ltd. is listed on HKEX. Which country or territory is Tianda Pharmaceuticals listed under? Our directory records Tianda Pharmaceuticals Ltd. under Hong Kong. What does Tianda Pharmaceuticals do? Our directory classifies Tianda Pharmaceuticals Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Tianda Pharmaceuticals? The ISIN recorded for Tianda Pharmaceuticals Ltd. is KYG887471038. Does aibio.space cover Tianda Pharmaceuticals? aibio.space lists Tianda Pharmaceuticals Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Tianda Pharmaceuticals? Companies in our directory listed in the same country and business area as Tianda Pharmaceuticals: China Biotech Services Holdings, SSY Group, Extrawell Pharmaceutical Holdings, China Resources Pharmaceutical Group, HUTCHMED (China), Pak Fah Yeow International. ## Investor discussion: Tianda Pharmaceuticals Members talk about Tianda Pharmaceuticals (455). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Tianda Pharmaceuticals, newest first. Each line links the filing it comes from. 1. 2026-04-29 Financings Share or debt issue: PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042901978.pdf) 2. 2025-04-30 Financings Share or debt issue: PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0430/2025043002053.pdf) ## Press releases Headlines of Tianda Pharmaceuticals's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-29 HKEXnews [Notification Letter and Request Form to Non-Registered Shareholders](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0929/2026092901047.pdf) 2. 2026-09-29 HKEXnews [Notification Letter and Reply Form to Registered Shareholders](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0929/2026092901039.pdf) 3. 2026-08-10 HKEXnews [2026 INTERIM RESULTS ANNOUNCEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0810/2026081001376.pdf) 4. 2026-06-12 HKEXnews [POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 12 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061201037.pdf) 5. 2026-04-29 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042902032.pdf) 6. 2026-04-29 HKEXnews [PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042901978.pdf) 7. 2026-04-29 HKEXnews [CLOSURES OF REGISTER OF MEMBERS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042901674.pdf) 8. 2026-03-26 HKEXnews [FINAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032603110.pdf) 9. 2025-08-28 HKEXnews [CHANGE OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0828/2025082802370.pdf) 10. 2025-08-28 HKEXnews [2025 INTERIM RESULTS ANNOUNCEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0828/2025082802352.pdf) 11. 2025-07-23 HKEXnews [CHANGE OF HONG KONG SHARE REGISTRAR AND TRANSFER OFFICE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0723/2025072300503.pdf) 12. 2025-06-27 HKEXnews [TERMS OF REFERENCE OF THE NOMINATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0627/2025062701547.pdf) 13. 2025-06-27 HKEXnews [CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE AND DESIGNATION OF LEAD INDEPENDENT NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0627/2025062701523.pdf) 14. 2025-06-13 HKEXnews [POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 13 JUNE 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0613/2025061300933.pdf) 15. 2025-04-30 HKEXnews [Notification Letter](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0430/2025043002128.pdf) 16. 2025-04-30 HKEXnews [PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; RE-ELECTION OF RETIRING DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0430/2025043002053.pdf) 17. 2025-03-28 HKEXnews [FINAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0328/2025032804342.pdf) 18. 2025-03-25 HKEXnews [PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0325/2025032500771.pdf) 19. 2024-12-18 HKEXnews [(I) REVISION OF EXPIRY DATE FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH TCH (CHINA) GROUP AND (II) RENEWAL OF FRAMEWORK AGREEMENT WITH TCH (CHINA) GROUP](https://www1.hkexnews.hk/listedco/listconews/sehk/2024/1218/2024121800659.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:455 on TradingView](https://www.tradingview.com/symbols/HKEX-455/). ## Listing details Tianda Pharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 455, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Tianda Pharmaceuticals Ltd. - **Ticker**: 455 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG887471038 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-455/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tianda-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Tianda Pharmaceuticals (455) stock and investor profile", 2026-10-31, https://aibio.space/companies/tianda-pharmaceuticals/